Breast Cancer Chemosensitivity
In Breast Cancer Chemosensitivity, a group of world leading experts review critical aspects of resistance to systemic therapy in breast cancer patients. Beginning with a clinical overview of the problem Breast Cancer Chemosensitivity moves on to focus on the latest findings of molecular mechanisms o...
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
New York, NY :
Springer New York,
2007.
|
| Series: | Advances in Experimental Medicine and Biology,
608 |
| Subjects: | |
| Online Access: | Full Text via HEAL-Link |
Table of Contents:
- Overview of Resistance to Systemic Therapy in Patients with Breast Cancer
- Roles of Multidrug Resistance Genes in Breast Cancer Chemoresistance
- Therapy-Induced Apoptosis in Primary Tumors
- Cell Cycle Deregulation in Breast Cancer: Insurmountable Chemoresistance or Achilles’ Heel?
- p53, BRCA1 and Breast Cancer Chemoresistance
- Integrin-Mediated Adhesion: Tipping the Balance between Chemosensitivity and Chemoresistance
- Insulin-Like Growth Factors and Breast Cancer Therapy
- EGF Receptor in Breast Cancer Chemoresistance
- Molecular Mechanisms of ErbB2-Mediated Breast Cancer Chemoresistance
- Estrogen Receptors in Resistance to Hormone Therapy
- Novel Approaches for Chemosensitization of Breast Cancer Cells: The E1A Story.